| Hazard Information | Back Directory | [Uses]
SDZ-62-434 is a platelet-activating factor (PAF) antagonist. SDZ-62-434 has antiproliferative activity in human solid and haematological malignancies[1]. | [References]
[1] V G Brunton, et al. In vitro antitumour activity of the novel imidazoisoquinoline SDZ 62-434. Br J Cancer. 1993 May;67(5):989-95. DOI:10.1038/bjc.1993.181 |
|
|